Browse News

Found 4,826 articles

• Ophthalmic Drug Delivery Devices Market Insights, New Innovations, Research and Growth Factor till 2027

  8/19/2022

  Wilmington, Delaware, United States, Transparency Market Research Inc. – Products and tools in the global ophthalmic drug delivery devices market are aimed at treating various ophthalmic disease conditions that can affect various parts of the human eye and ocular systems.

• Piramal Critical Care Launches First to Market Generic Zinc Sulfate Injection in the U.S.

  8/18/2022

  Piramal Pharma Limited's Critical Care business, a leading Complex Hospital Generics company, announces First to Market Generic U.S. launch of Zinc Sulfate Injection.

• Hyperhidrosis Treatment Market Research on Size, Leading Players and Growth Forecast To 2027

  8/18/2022

  According to the current analysis of Reports and Data, the global hyperhidrosis treatment market was valued at USD 1.27 Billion in 2019 and is expected to reach USD 2.10 Billion by the year 2027, at a CAGR of 6.0%.

• Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Report 2022 to 2030

  8/18/2022

  Rise in Focus on Research & Development and Surge in Number of People with Diabetes Mellitus: Key Drivers of Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market

• Experience the JUVÉDERM® Difference with Allergan Aesthetics

  8/17/2022

  Allergan Aesthetics, an AbbVie company, invites consumers to experience the JUVÉDERM® difference.

• Mallinckrodt Announces Appointment of Karen Ling to Its Board of Directors

  8/17/2022

  Mallinckrodt plc, a global specialty pharmaceutical company, announced that Karen Ling has been appointed to the Company's Board of Directors, effective August 12, 2022.

• Pruritus Therapeutics Market Size Worth USD 19.98 Billion By 2028

  8/17/2022

  According to the current analysis of Reports and Data, the global Pruritus Therapeutics market was valued at USD 12.40 Billiion in 2020 and is expected to reach USD 19.98 Billion by year 2028, at a CAGR of 6.23 percent.

• Non-Alcoholic Steatohepatitis (NASH) Market Will Reach USD 180.09 Billion By 2028

  8/17/2022

  The global Non-alcoholic Steatohepatitis (NASH) market is expected to reach USD 180.09 Billion by 2028, according to a new report by Reports and Data.

• Ocular Hypertension Treatment Market: Increase in incidence of ophthalmic diseases to Drive the Market

  8/17/2022

  Wilmington, Delaware, United States, Transparency Market Research Inc. – Ocular hypertension is caused by poor drainage of the fluid inside the eye.

• Aesthetic Medicine Market Segmentation and Analysis Report, 2031

  8/16/2022

  Wilmington, Delaware, United States, Transparency Market Research Inc. – In the last few years, the manufacturers have created novel aesthetic gadgets, resulting in a rise in demand for aesthetic treatments.

• Increased Prevalence of Eye Infections is Expected to Drive Acute Conjunctivitis Market Revenue Growth till 2030

  8/16/2022

  The latest market analysis report published by Reports and Data, titled ‘Global Acute Conjunctivitis Market – Forecast to 2030,’ thoroughly examines the Acute Conjunctivitis industry to provide essential data & information for the targeted readers

• North America Cluster Headache Market is Expected to Register Highest Revenue Share During the Forecast Period 2022-2030

  8/16/2022

  The latest market analysis report published by Reports and Data, titled ‘Global Cluster Headache Market – Forecast to 2030,’ thoroughly examines the Cluster Headache industry to provide essential data & information for the targeted readers.

• Substance Abuse Treatment Market: Rising Prevalence of Various Lifestyle Diseases to Drive the Market

  8/15/2022

  Wilmington, Delaware, United States, Transparency Market Research Inc. – The term 'substance abuse' refers to a pattern of drug or substance usage that results in serious issues or distress.

• RVL Pharmaceuticals plc Reports Second Quarter 2022 Financial Results; Provides Commercial Update

  8/11/2022

  RVL Pharmaceuticals plc, a specialty pharmaceutical company, announced financial results and business highlights for the three months ended June 30, 2022.

• Cingulate Inc. Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update

  8/11/2022

  Cingulate Inc. announced its financial results for the quarter ended June 30, 2022, and provided a clinical and business update.

• Histogen Reports Second Quarter 2022 Financial Results and Provides Business Update

  8/11/2022

  Histogen Inc. (NASDAQ: HSTO), today reported financial results for the second quarter ended June 30, 2022 and provided an update on its clinical pipeline and other corporate developments.

• Glaucoma Surgery Devices Market Size Surpass USD 3.16 BN by 2030

  8/11/2022

  According to Latest Study, the global glaucoma surgery devices market was valued at USD 15 billion in 2021 and it is predicted to surpass around USD 3.16 billion by 2030 with a CAGR of 7.7% from 2022 to 2030

• Revance Reports Second Quarter 2022 Financial Results, Provides Corporate Update

  8/9/2022

  Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today reported financial results for the second quarter ended June 30, 2022 and provided a corporate update.

• Crohn’s Disease Therapeutics Market, 2031| Drivers | Restraints | Competitive Analysis | Latest Trends and Opportunities

  8/9/2022

  The report details an exhaustive account of the global Crohn’s disease therapeutics market along with numerous associated factors.

• Menopausal Hot Flashes Treatment Market Analysis of the Competitive Landscape, with a Forecast for 2027

  8/9/2022

  Wilmington, Delaware, United States, Transparency Market Research Inc. – As per the research report by TMR, the menopausal hot flashes market is estimated to reach a CAGR of 6% during the forecast period starting from 2019 to 2027.